With MSB,s Acquisition of U.S.A based Angioblast systems, makes MSB The world?s largest Stem cell company, and the fourth largest Australian biotech company, behind Majors CSL, Cochlear and ResMed. Its interesting to note the first mentioned two are at $32 and $69 respectively.(and incidently they retracted over the last five trading days. MSB advanced 2% over the same period)Then again they are making big profits our turn is coming. So my envision is to see MSB,s share price value to be sitting somewhere between the two majors within 5 years, and i believe that is being conserative .Cheers holders .... and we are growing .....
With MSB,s Acquisition of U.S.A based Angioblast systems, makes...
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.35 |
Change
0.105(8.43%) |
Mkt cap ! $1.541B | |||
| Open | High | Low | Value | Volume |
| $1.27 | $1.40 | $1.27 | $16.46M | 12.22M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 6 | 59739 | $1.35 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.36 | 5000 | 1 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |